Skip to main content
Erschienen in: BMC Ophthalmology 1/2020

Open Access 01.12.2020 | Case report

CT and MRI findings in relapsing primary malignant melanoma of the lacrimal sac: a case report and brief literature review

verfasst von: Ju-Wei Shao, Jian-Hua Yin, Shu-Tian Xiang, Qian He, Hong Zhou, Wei Su

Erschienen in: BMC Ophthalmology | Ausgabe 1/2020

Abstract

Background

Primary lacrimal sac melanoma is an extremely rare condition with fewer than 50 cases reported so far. Clinically, its symptoms resemble those of dacryocystitis, leading to frequent misdiagnosis. During diagnosis, imaging examination is often performed to differentiate tumors from inflammation. In this report, we present a case of primary lacrimal sac melanoma and summarize the CT and MRI characteristics of lacrimal sac melanoma.

Case presentation

We report a 50-year-old female patient who had undergone a dacryocystectomy for the left lacrimal sac mass. Postoperative pathological examination confirmed the presence of primary malignant melanoma. Three months later, a lump in the lacrimal sac area was found. The patient underwent CT and MR examinations. CT scan demonstrated a partially well-defined soft mass in the fossa of left lacrimal sac extending into the nasolacrimal duct and anterior ethmoid sinus. MRI revealed an intermediate signal intensity on T1 and iso-or hyper-signal on T2 weighted images. Histopathological examination on biopsy confirmed recurrence of primary lacrimal sac melanoma.

Discussion and conclusions

None has described the CT and MR findings of primary lacrimal sac melanoma so far. Typically, MR images show hyperintensity signal on T1-weighted images and hypointense signal on T2-weighted images owing to the paramagnetic properties of melanin. In contrast to previous reports and the present case, most cases do not present these typical signals. Thus, reporting such radiological findings is important to create awareness on variant images of primary lacrimal sac melanoma. This will reduce misdiagnosis and mistreatment.
Hinweise
Ju-Wei Shao and Jian-Hua Ying are Co-first author

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
AES
Anterior ethmoid sinus
CT
Computed tomography
IM
Inferior meatus
MOW
Medial orbital wall
MRI
Magnetic resonance imaging
NC
Nasal cavity
ND
Nasolacrimal duct
STM
Soft tissue mass

Background

Primary malignant melanoma of the lacrimal sac is an extremely rare condition. Yet, the lesion is highly malignant, can metastasize at a relatively early stage and patients with such lesions have poor prognosis. Early diagnosis is therefore essential. Notably, this condition is often misdiagnosed as chronic dacryocystitis. For accurate diagnosis, imaging examination is recommended to assess the severity of the disease, differentiate between tumors and inflammation and characterize tumor features. Here, we present a case of primary malignant melanoma of the lacrimal sac. We provide a summarize of the computed tomography (CT) and magnetic resonance imaging (MRI) findings and review previous literature on this condition.

Case presentation

A 50-year-old female patient who had a mass in the lacrimal sac area for more than 3 months is presented in this report. The mass exhibited slow but progressive swelling. She experienced occasional epiphora and pain, without blood discharge or impaired vision. After 6 months, the patient underwent dacryocystectomy for the left lacrimal sac mass. Postoperative pathological examination confirmed the presence of malignant melanoma. Three months after the operation, a lump in the lacrimal sac area had gradually increased. Local recurrence was suspected and she was referred to ophthalmology department for further treatment.
A physical examination revealed a scar from the previous operation. In addition, a 1.5 cm × 1.5 cm firm, localized and relatively clearly defined mass was observed in the left medial canthus. There was no cervical lymphadenopathy. A CT scan demonstrated a partially well-defined soft mass in the fossa of left lacrimal sac extending into the nasolacrimal duct and anterior ethmoid sinus (Fig. 1a). CT plain scan revealed that the lesion had a CT value of 49HU. The CT value of the tumor was similar to that of the extraocular muscle and wall of eyeball. Enhanced CT scan detected a CT value of 103HU for the arterial phase and 95HU for the venous phase (Fig. 1b). There was no eyeball involvement. Bone windows showed that the left nasolacrimal duct was enlarged and partial bone destruction of the nasolacrimal duct was confirmed. There was no regional or distant metastasis.
MRI plain scan demonstrated a partly well-demarcated mass of 1.2 cm × 1.3 cm × 2.3 cm in the lacrimal sac lesion. The tumors had infiltrated the septa orbital and subcutaneous adipose tissue. MRI revealed intermediate signal intensity on T1 and iso-or hyper-signal on T2 weighted images (Fig. 1c, d). The lesions displayed slight hyperintense signal on DWI. A dynamically enhanced MRI scan showed intense enhancement of the lesion margin and inhomogeneous enhancement of the lesion center (Fig. 1e).
A biopsy was obtained from the patient before the operation. Histopathological examination on the biopsy confirmed fusiform malignant tumoral cells with hyperchromatic nuclei. The tumor had high number of pigmented cells, inhomogeneous pigment granules and massive hemorrhage (Fig. 1f, g). Immunoreactivity to the S-100 protein, Melan-A, HMB-45, Nestin, and CD56 was positive (Fig. 1h, i). Therefore, a diagnosis of malignant melanoma was confirmed. Further examination of the whole body, including computed tomography scanning and B ultrasound revealed that there was no metastasis in the head and neck, chest, abdomen, and pelvis regions. Thus, total excision of tumor was performed. The patient refused to undergo radiotherapy and chemotherapy.

Discussion and conclusions

Primary malignant melanoma of the lacrimal sac is a rare condition, with less than 50 cases reported over the past 90 years worldwide. The first case of this disease was published in 1926 in Russia by Muravleskin [1]. The incidence of primary lacrimal sac melanoma in lacrimal sac tumors ranges between 4 and 13% and it accounts for 0.7% of all ocular melanomas [2]. Melanoma cells are neuroectodermal tumors that originate from the neural crest. However, lacrimal sac epithelium does not contain melanocytic cells. It is speculated that malignant melanoma develops from melanin cells left in the epithelium of the lacrimal sac during the development of the embryonic system [3]. Based on a review of previous reports, the average age of patients at diagnosis is 59 years old (range of 27–81) with no significant sex predilection [1]. Primary melanomas of the lacrimal sac have a poor prognosis [2]. Clinically, its symptoms resemble those of dacryocystitis, leading to frequent misdiagnosis. Blood discharge (44%) and painless swelling (42%) are the most frequent symptoms of this condition. Due to its insidious onset, understanding the extent of invasion and early diagnosis are critical to facilitate timely intervention and improve the survival outcomes [1]. Although pathology and immunohistochemistry tests are needed to make a definitive diagnosis, CT and MRI imaging are also effective diagnostic tools for this condition [4]. Several reports on CT-scan for lacrimal sac melanoma show the presence of a soft lesion in the lacrimal sac fossa (Table 1). Similarly, our case presented isodensity and slightly high density on CT images, without calcification. Cystic change is uncommon.
Table 1
Description of CT findings in primary malignant melanoma of the lacrimal sac
case
references
CT density
extending area
bone destruction
1
Lloyd and Leone (1984) [5]
STM
a
a
2
Eide et al. (1993) [6]
STM
a
no
3
Owens et al. (1995) [7]
STM
ND and IM
a
4
Levine et al. (1996) [8]
STM
a
no
5
TY Malik et al. (1997) [9]
STM
a
no
6
Fishman and Ophir (1999) [10]
STM
ND, IM and NC
a
7
Lee et al. (2001)[11]
STM
ND and IM
a
8
Billing et al. (2003) [12]
STM
ND
no
9
Tello et al. (2004)[13]
STM
ND
no
10
Gleizal et al. (2005) [4]
STM
a
no
11
Nam et al. (2006)[14]
STM
ND and MOW
a
12
Lewis et al. (2006)[15]
STM
ND
no
13
Sitole et al. (2007)[16]
STM
a
posterior lacrimal duct wall
14
Heindl et al. (2008)[17]
STM
ND and NC
no
15
Li et al. (2012) [18]
STM
MOW
nasolacrimal canal and inferior turbinate
16
Maegawa et al. (2014) [19]
STM
ND and IM
a
17
Ren et al. (2014) [20]
STM
a
no
18
Pujari et al. (2014) [21]
isodense
a
anterior lacrimal crests infiltration
19
McGrath et al. (2016) [1]
STM
a
the lateral wall of upper nasal canal and anterior ethmoidal air cells
20
Kavoussi et al. (2016) [22]
STM
a
ethmoid sinuses
21
Present case
Isodense, slightly high
ND and AES
ND
STM soft tissue mass, ND nasolacrimal duct, IM inferior meatus, NC nasal cavity, MOW medial orbital wall, AES anterior ethmoid sinus, a: not mentioned
In the early stage, imaging examination showed round, well-defined and homogeneous density lesions without orbital or nasal sinus involvement. Nasolacrimal duct is easily involved [4], according to previous literatures on CT images, the lesions extend into the nasolacrimal duct without nasolacrimal duct bone destruction, accounting for 50% (10/20) of CT images (Table 1), after which they invade the surrounding bone and soft tissue. In the late stage, the lesions tended to be irregular and ill-defined masses with invasion of nasolacrimal duct, orbital and sinus [22]. CT is more sensitive to bone destruction than MRI [4]. Non-epithelial lesions appear to cause lower bone destruction than epithelial tumors. In accordance with previous imaging findings, only five cases mentioned bone destruction on CT imagines (5/20) (Table 1). Because our case is a relapsing primary malignant melanoma of the lacrimal sac after surgery, bone destruction may result from the previous dacryorhiocydtostomy. The operation was done in other hospitals. There was no CT before the operation. Unfortunately, we don’t know the exact cause of bone destruction.
Of note, CT is not sufficient for tumor diagnosis because CT values do not show the number of melanin granules. In contrast, MRI images provide effective diagnosis for malignant melanoma. MRI has a high soft-tissue resolution, making it the best imaging technique for evaluating malignant melanoma currently. Typically, MR images show the presence of hyperintensity signal on T1-weighted images and hypointense signal on T2-weighted images owing to the paramagnetic properties of melanin in most other parts of malignant melanomas. But this condition is rare in malignant melanoma of lacrimal sac. To the best of our knowledge, only six case reports have been published describing the MRI radiological features of this condition. Four cases (4/7) (including our case) show intermediate signal intensity on T1 weighted image, and only one case presented with typical signals on T2 weighted images (Table 2).
Table 2
Description of MR findings in primary malignant melanoma of the lacrimal sac
case
references
MR features
1
Billing et al. (2003) [12]
intermediate signal intensity on T1 and T2 weighted images, enhanced with intravenous gadolinium
2
Tello et al. (2004) [13]
intermediate signal intensity on T1 weighted images and hyperintensity on T2 weighted images
3
Lewis et al. (2006) [15]
iso-or hyper-signal on T1 weighted images
4
Li et al. (2012) [18]
lowerintensity on T1 weighted images and highintensity on T2 weighted images, gadolinium-enhanced T1-weighted highintensity
5
Maegawa et al. (2014) [19]
hypointense on T2
6
Kavoussi et al. (2016) [22]
intermediate signal intensity on T1 and T2 weighted images
7
Present case
intermediate signal intensity on T1 weighted images and iso-or hyper-signal on T2 weighted images
The characteristic MR signals are based on histologic features. The higher the melanin content, the more typical the signal is. In our case, massive hemorrhage and inhomogeneous pigmentation may precipitate the untypical signals, and since after only 3 months theretumor blood supply and structure could still be some post-surgical changes in MR signals. This untypical signal may lead to misdiagnosis of amelanotic melanoma, which accounts for 2% of all cases of melanoma [23]. The malignant melanoma of the lacrimal sac contains fewer melanocytes than uveal melanoma. Compared with other parts of orbital malignant melanoma images, fewer cases present with the typical paramagnetic signals. Less pigmentation and intratumoral hemorrhage may cause untypical MR signals in the lacrimal sac, and therefore they should be considered during diagnosis. Malignant melanoma of the lacrimal sac may present intermediate signal intensity on T1 and iso-or hyper-signal on T2 weighted images in most cases. Intravenous gadolinium provides more information on tumor blood supply and structure [22]. However, only one case mentioned moderated image enhancement of lesions excluding our case. The patient in this report exhibited marked enhancement of lesions, suggesting hypervascular neoplasms. According to previous studies, many orbital melanomas contain moderate and intense enhancement lesions following the administration of contrast material [24]. Contrast enhancement may improve the detection. Unfortunately, contrast enhanced cases are few and thus the characteristics of melanoma of lacrimal sac cannot be summarized.
The differential diagnosis of melanoma in the lacrimal sac considers primary epithelial neoplasms (85.6%), malignant lymphoma (7.8%), neural tumors, inflammatory lesions and metastatic tumor [25]. Cases with well-defined lesions extending into the nasolacrimal duct with minimal bone destruction are likely to be nonepithelial neoplasms. Most lacrimal sac tumors present intermediate signal intensity on T1 and T2 weighted images. Typical signals of malignant melanoma of lacrimal sac are rare, so high scrutiny is required to identify them. Imaging can diagnose cystic mass [26]. Imaging examination can effectively identify the location, size, extent of lesions, and invasion of adjacent soft tissue. The CT and MRI examinations are suitable for determining tumor recurrence during patient follow-up. Imaging examination provides more reliable information to guide decision-making in the choice of clinical treatment. Definite diagnosis should be made by pathologic evaluation and immunohistochemistry. A limitation of this case report is that imaging was only performed at the relapsing stage, and thus bone destruction may result from tumor development or from the initial surgery (or both).
To date, none has summarized the CT and MR findings on primary lacrimal sac melanoma. Based on previous reports and our case, most cases do not present typical signals. Thus, reporting such radiological findings is important to create awareness on variant images of primary lacrimal sac melanoma. This will reduce misdiagnosis and mistreatment.

Acknowledgements

We thank each author who contributed to this paper, especially thank Dr. Hong Zhou for her excellent assistance in the histopathologic procedures.
Not applicable.
The patient clarified and gave written consent to use of the clinical information, CT and MR images for publication in the BMC Ophthalmology.

Competing interests

The authors declare that they have no competing interests.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
2.
Zurück zum Zitat Subramaniam SS, Anand R, et al. Primary lacrimal sac melanoma with metastatic cervical disease: a review of the literature and case report. J Oral Maxil Surg. 2017;75:1438–41.CrossRef Subramaniam SS, Anand R, et al. Primary lacrimal sac melanoma with metastatic cervical disease: a review of the literature and case report. J Oral Maxil Surg. 2017;75:1438–41.CrossRef
3.
Zurück zum Zitat Heindl LM, Jünemann AG, Kruse FE, et al. Tumors of the lacrimal drainage system. Orbit. 2010;29(5):298–306.CrossRef Heindl LM, Jünemann AG, Kruse FE, et al. Tumors of the lacrimal drainage system. Orbit. 2010;29(5):298–306.CrossRef
4.
Zurück zum Zitat Gleizal A, Kodjikian L, Lebreton F, et al. Early CT-scan for chronic lacrimal duct symptoms-case report of a malignant melanoma of the lacrimal sac and review of the literature. J Cranio Maxill Surg. 2005;33:201–4.CrossRef Gleizal A, Kodjikian L, Lebreton F, et al. Early CT-scan for chronic lacrimal duct symptoms-case report of a malignant melanoma of the lacrimal sac and review of the literature. J Cranio Maxill Surg. 2005;33:201–4.CrossRef
5.
Zurück zum Zitat W. C. Lloyd, C. R. Leone, (1984) Malignant Melanoma of the Lacrimal Sac. Archives of Ophthalmology 102 (1):104-107. W. C. Lloyd, C. R. Leone, (1984) Malignant Melanoma of the Lacrimal Sac. Archives of Ophthalmology 102 (1):104-107.
6.
Zurück zum Zitat Eide N, Refsum SB, Bakke S, Primary malignant melanoma of the lacrimal sac. Acta Ophthalmol (Copenh) .1993;71(2):273-6. Eide N, Refsum SB, Bakke S, Primary malignant melanoma of the lacrimal sac. Acta Ophthalmol (Copenh) .1993;71(2):273-6.
7.
Zurück zum Zitat Owens RM, Wax MK, Kostik D, et al. Malignant melanoma of the lacrimal sac. Otolaryngol Head Neck Surg.1995;113(5):634-40. Owens RM, Wax MK, Kostik D, et al. Malignant melanoma of the lacrimal sac. Otolaryngol Head Neck Surg.1995;113(5):634-40.
8.
Zurück zum Zitat Levine MR, Dinar Y, Davies R, et al. Malignant melanoma of the lacrimal sac. Ophthalmic Surg Lasers.1996;27(4):318-20. Levine MR, Dinar Y, Davies R, et al. Malignant melanoma of the lacrimal sac. Ophthalmic Surg Lasers.1996;27(4):318-20.
9.
Zurück zum Zitat TY Malik, R Sanders, JDH Young, et al. Malignant melanoma of the lacrimal sac. Eye.1997; 11,935-945. TY Malik, R Sanders, JDH Young, et al. Malignant melanoma of the lacrimal sac. Eye.1997; 11,935-945.
10.
Zurück zum Zitat Fishman G, Ophir D. Malignant melanoma of the lacrimal sac: a case study. Am J Otolaryngol.1999 ;20(5);336-9. Fishman G, Ophir D. Malignant melanoma of the lacrimal sac: a case study. Am J Otolaryngol.1999 ;20(5);336-9.
11.
Zurück zum Zitat Lee HM, Kang HJ, Choi G, et al. Two cases of primary malignant melanoma of the lacrimal sac. Head Neck.2001,23(9);809-13. Lee HM, Kang HJ, Choi G, et al. Two cases of primary malignant melanoma of the lacrimal sac. Head Neck.2001,23(9);809-13.
12.
Zurück zum Zitat Billing K, Malhotra R, Selva D, et al. Magnetic resonance imaging findings in malignant melanoma of the lacrimal sac. Br J Ophthalmol. 2003; 87:1187-8. Billing K, Malhotra R, Selva D, et al. Magnetic resonance imaging findings in malignant melanoma of the lacrimal sac. Br J Ophthalmol. 2003; 87:1187-8.
13.
Zurück zum Zitat Tello JS, Campillo NG, Rodriguez JL, et al. Malignant melanoma of the lacrimal sac. Otolaryngol Head Neck Surg. 2004;131:334-6. Tello JS, Campillo NG, Rodriguez JL, et al. Malignant melanoma of the lacrimal sac. Otolaryngol Head Neck Surg. 2004;131:334-6.
14.
Zurück zum Zitat Nam JH, Kim SM, Cho JH, et al. Primary malignant melanoma of the lacrimal sac: a case report. Korean J Intern Med. 2006;21(4):248-51. Nam JH, Kim SM, Cho JH, et al. Primary malignant melanoma of the lacrimal sac: a case report. Korean J Intern Med. 2006;21(4):248-51.
15.
Zurück zum Zitat AM Lewis, PM Clarke, JM Olver. Primary nasolacrimal duct malignant mucosal melanoma. Br J Ophthalmol.2006;90:114-125. . AM Lewis, PM Clarke, JM Olver. Primary nasolacrimal duct malignant mucosal melanoma. Br J Ophthalmol.2006;90:114-125. .
16.
Zurück zum Zitat Sitole S, Zender CA, Ahmad AZ, et al. Lacrimal sac melanoma. Ophthal Plast Reconstr Surg.2007;23(5):417-9. Sitole S, Zender CA, Ahmad AZ, et al. Lacrimal sac melanoma. Ophthal Plast Reconstr Surg.2007;23(5):417-9.
17.
Zurück zum Zitat Heindl LM, Schick B, Kämpgen E, et al. Malignant melanoma of the lacrimal sac. Ophthalmologe.2008;105(12):1146-9. Heindl LM, Schick B, Kämpgen E, et al. Malignant melanoma of the lacrimal sac. Ophthalmologe.2008;105(12):1146-9.
18.
Zurück zum Zitat Li YJ, Zhu SJ, Yan H, et al. Primary malignant melanoma of the lacrimal sac. BMJ Case Rep.2012;13:2012. Li YJ, Zhu SJ, Yan H, et al. Primary malignant melanoma of the lacrimal sac. BMJ Case Rep.2012;13:2012.
19.
Zurück zum Zitat Maegawa J, Yasumura K, Iwai T, et al. Malignant melanoma of the lacrimal sac: a case report. Int J Dermatol.2014;53(2):243-5. Maegawa J, Yasumura K, Iwai T, et al. Malignant melanoma of the lacrimal sac: a case report. Int J Dermatol.2014;53(2):243-5.
20.
Zurück zum Zitat Ren M, Zeng JH, Luo QL, et al. Primary malignant melanoma of lacrimal sac. Int J Ophthalmol.2014;7(6):1069-70. Ren M, Zeng JH, Luo QL, et al. Primary malignant melanoma of lacrimal sac. Int J Ophthalmol.2014;7(6):1069-70.
21.
Zurück zum Zitat Pujari A, Ali MJ, Mulay K, et al. The black lacrimal sac: a clinicopathological correlation of a malignant melanoma with anterior lacrimal crest infiltration. Int Ophthalmol.2014;34(1):111-5. Pujari A, Ali MJ, Mulay K, et al. The black lacrimal sac: a clinicopathological correlation of a malignant melanoma with anterior lacrimal crest infiltration. Int Ophthalmol.2014;34(1):111-5.
22.
Zurück zum Zitat Kavoussi SC, Levin F, Servat JJ. Orbital Extension of Untreated Lacrimal Sac Melanoma Following Dacryocystorhinostomy. Ophthal Plast Reconstr Surg. 2016; 32: e76. Kavoussi SC, Levin F, Servat JJ. Orbital Extension of Untreated Lacrimal Sac Melanoma Following Dacryocystorhinostomy. Ophthal Plast Reconstr Surg. 2016; 32: e76.
23.
Zurück zum Zitat Lorenzano D, Miszkiel K, Rose GE. Orbital melanoma masquerading as a "Galloping haemangioma". Orbit. 2017; 36:81-3. Lorenzano D, Miszkiel K, Rose GE. Orbital melanoma masquerading as a "Galloping haemangioma". Orbit. 2017; 36:81-3.
24.
Zurück zum Zitat Purohit BS, Vargas MI, Ailianou A. Becker, M; Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging. Insights Imaging. 2016;7(1):43-68. Purohit BS, Vargas MI, Ailianou A. Becker, M; Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging. Insights Imaging. 2016;7(1):43-68.
25.
Zurück zum Zitat Song XM, Wang J, Wang S, et al. Clinical analysis of 90 cases of malignant lacrimal sac tumor. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1333-1338. .  Song XM, Wang J, Wang S, et al. Clinical analysis of 90 cases of malignant lacrimal sac tumor. Graefes Arch Clin Exp Ophthalmol. 2018;256(7):1333-1338. .
26.
Zurück zum Zitat Deep P, Rand R, Sylvia K. Primary lacrimal sac diffuse large B-cell lymphoma in a child[J]. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2019, 23(1):53-55. Deep P, Rand R, Sylvia K. Primary lacrimal sac diffuse large B-cell lymphoma in a child[J]. Journal of AAPOS: the official publication of the American Association for Pediatric Ophthalmology and Strabismus. 2019, 23(1):53-55.
Metadaten
Titel
CT and MRI findings in relapsing primary malignant melanoma of the lacrimal sac: a case report and brief literature review
verfasst von
Ju-Wei Shao
Jian-Hua Yin
Shu-Tian Xiang
Qian He
Hong Zhou
Wei Su
Publikationsdatum
01.12.2020
Verlag
BioMed Central
Erschienen in
BMC Ophthalmology / Ausgabe 1/2020
Elektronische ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-020-01356-6

Weitere Artikel der Ausgabe 1/2020

BMC Ophthalmology 1/2020 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.